Department of Radiology

Publications

2023

Mauguen A, Grewal RK, Augensen F, Abusamra M, Mahajan S, Jayaprakasam VS, et al. The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients. Eur J Nucl Med Mol Imaging. 2023;50(10):2971-2983.

Rodriguez J, Martinez G, Mahase S, Roytman M, Haghdel A, Kim S, et al. Cost-Effectiveness Analysis of 68Ga-DOTATATE PET/MRI in Radiotherapy Planning in Patients with Intermediate-Risk Meningioma. AJNR Am J Neuroradiol. 2023;44(7):783-791.

Zhu C, Dev H, Sharbatdaran A, He X, Shimonov D, Chevalier JM, et al. Clinical Quality Control of MRI Total Kidney Volume Measurements in Autosomal Dominant Polycystic Kidney Disease. Tomography. 2023;9(4):1341-1355.

Motovilova E, Ching T, Vincent J, Shin J, Tan ET, Taracila V, et al. Dual-Channel Stretchable, Self-Tuning, Liquid Metal Coils and Their Fabrication Techniques. Sensors (Basel). 2023;23(17).

Dimov AV, Li J, Nguyen TD, Roberts AG, Spincemaille P, Straub S, et al. QSM Throughout the Body. J Magn Reson Imaging. 2023;57(6):1621-1640.

Gayger-Dias V, Vizuete AF, Rodrigues L, Wartchow KM, Bobermin L, Leite MC, et al. How S100B crosses brain barriers and why it is considered a peripheral marker of brain injury. Exp Biol Med (Maywood). 2023:15353702231214260.

Soliman MM, Kim T-, Cheng M, McKenney AS, Fassia M-, Lamparello NA, et al. Mentorship in Radiology Research: A Guide for Mentors and Mentees. Radiol Imaging Cancer. 2023;5(6):e230176.

Parikh D, Choksi E, Reeves R, Winokur RS, Tan A, Weinstein J, et al. Characterizing Trends in Chronic Superficial Venous Disease Treatment among Medicare Beneficiaries from 2010 to 2018. J Vasc Interv Radiol. 2023.

Luo Y, Yamada M, N'Tumba-Byn T, Asif H, Gao M, Hu Y, et al. SPRY4-dependent ERK negative feedback demarcates functional adult stem cells in the male mouse germline†. Biol Reprod. 2023;109(4):533-551.

Chernov V, Rybina A, Zelchan R, Medvedeva A, Bragina O, Lushnikova N, et al. Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors. Cancers (Basel). 2023;15(6).